[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:huntington-s-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":164,"states":169},"Huntington's Disease",25,21,[8,16,22,29,35,42,48,54,60,66,72,78,84,90,96,102,108,114,120,126,132,138,145,151,158],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07451613","Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:00.709807Z","2026-05-05T02:43:29.711341Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05326451","Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease",[],"2026-08-26T02:19:16.454910Z","2026-05-05T02:43:29.682399Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07326709","A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease",[26],"Phase 3","2026-08-26T02:18:17.007929Z","2026-05-05T02:43:28.851619Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06826612","A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease",[12],"2026-08-26T02:18:58.958025Z","2026-05-05T02:43:27.953296Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT04396873","PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease",[39],"Phase 1","2026-08-26T02:18:09.641312Z","2026-05-05T02:43:26.747854Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT07010705","Digital Measures for Clinical Trial Endpoints in Huntington's Disease",[],"2026-08-26T02:18:06.247899Z","2026-05-13T02:55:06.606997Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06941662","Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping",[],"2026-08-26T02:15:31.806698Z","2026-05-13T02:55:06.592099Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06546488","Cognitive Assessment Tools for Huntington's Disease.",[],"2026-08-26T02:18:34.622081Z","2026-05-13T02:55:06.510719Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06448546","Gut Microbiomes in HD",[],"2026-08-26T02:18:25.327036Z","2026-05-13T02:55:06.495232Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06475898","Longitudinal Endpoint Assessment of Disease Burden in HD",[],"2026-08-26T02:15:18.897219Z","2026-05-13T02:55:06.493353Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06082713","Extracellular Vesicles for HD",[],"2026-08-26T02:15:29.632183Z","2026-05-13T02:55:06.407475Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT02855476","HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease",[],"2026-08-26T02:17:14.343713Z","2026-05-13T02:55:06.102822Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT01574053","Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort",[],"2026-08-26T02:15:04.877798Z","2026-05-13T02:55:06.074646Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06876857","University of Central Florida CereBank",[],"2026-08-26T02:17:33.002248Z","2026-05-13T02:55:06.586815Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT06539169","FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases",[],"2026-08-26T02:18:44.395098Z","2026-05-13T02:55:06.551987Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT06203106","NYSCF Scientific Discovery Biobank",[],"2026-08-26T02:15:57.572488Z","2026-05-13T02:55:06.425562Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT03233646","Retinal Imaging in Neurodegenerative Disease",[],"2026-08-26T02:19:27.519777Z","2026-05-13T02:55:06.120078Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT03225144","Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia",[],"2026-08-26T02:19:31.671303Z","2026-05-13T02:55:06.119817Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT06843252","Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease",[],"2026-08-26T02:15:43.339060Z","2026-05-05T02:43:28.366517Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT06828471","Social Cognition Training in Individuals With Huntington's Disease",[],"2026-08-26T02:19:03.581490Z","2026-05-05T02:43:27.495441Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":27,"content_modified":137},"NCT05357612","Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases",[136],"Phase 4","2026-05-05T02:43:27.661695Z",{"nct_id":139,"title":140,"phases":141,"status":142,"updated_at":143,"content_modified":144},"NCT07315984","Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease",[],"NOT_YET_RECRUITING","2026-08-26T02:15:14.574786Z","2026-05-13T02:55:06.686302Z",{"nct_id":146,"title":147,"phases":148,"status":142,"updated_at":149,"content_modified":150},"NCT07280650","Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study",[],"2026-08-26T02:18:57.189473Z","2026-05-05T02:43:27.657962Z",{"nct_id":152,"title":153,"phases":154,"status":155,"updated_at":156,"content_modified":157},"NCT02994719","Gait Analysis in Neurological Disease",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:52:12.406209Z","2026-05-13T02:55:06.105137Z",{"nct_id":159,"title":160,"phases":161,"status":155,"updated_at":162,"content_modified":163},"NCT07213648","Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)",[],"2026-08-03T02:12:21.768801Z","2026-05-05T02:35:31.875120Z",[165],{"biomarker":166,"count":167,"slug":168},"HTT Gene",8,"htt-gene",[170,174,178,181,184,187,191,194,197,201,204,207,210,213],{"state":171,"count":172,"slug":173},"New York",6,"new-york",{"state":175,"count":176,"slug":177},"California",5,"california",{"state":179,"count":176,"slug":180},"Florida","florida",{"state":182,"count":176,"slug":183},"Tennessee","tennessee",{"state":185,"count":176,"slug":186},"Texas","texas",{"state":188,"count":189,"slug":190},"Maryland",4,"maryland",{"state":192,"count":189,"slug":193},"North Carolina","north-carolina",{"state":195,"count":189,"slug":196},"Ohio","ohio",{"state":198,"count":199,"slug":200},"Colorado",3,"colorado",{"state":202,"count":199,"slug":203},"District of Columbia","district-of-columbia",{"state":205,"count":199,"slug":206},"Illinois","illinois",{"state":208,"count":199,"slug":209},"Massachusetts","massachusetts",{"state":211,"count":199,"slug":212},"Michigan","michigan",{"state":214,"count":199,"slug":215},"Pennsylvania","pennsylvania"]